These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23238876

  • 1. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
    Doi SA, Clark J, Russell AW.
    Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
    [Abstract] [Full Text] [Related]

  • 2. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD, Rossi MA, Juárez-Allen L, Serra HA, Albiero MC.
    Medicina (B Aires); 2015 Apr; 75(6):373-8. PubMed ID: 26707659
    [Abstract] [Full Text] [Related]

  • 3. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F, Boscaro M.
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [Abstract] [Full Text] [Related]

  • 4. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H, Raff JL, Findling JW.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [Abstract] [Full Text] [Related]

  • 5. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F, Marcelli G, Martino M, Concettoni C, Brugia M, Trementino L, Michetti G, Arnaldi G.
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [Abstract] [Full Text] [Related]

  • 6. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F, Barbot M, Zilio M, Frigo AC, Albiger N, Camozzi V, Antonelli G, Plebani M, Mantero F, Boscaro M, Scaroni C.
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [Abstract] [Full Text] [Related]

  • 7. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.
    Carrasco CA, García M, Goycoolea M, Cerda J, Bertherat J, Padilla O, Meza D, Wohllk N, Quiroga T.
    Endocrine; 2012 Jun; 41(3):487-93. PubMed ID: 22270871
    [Abstract] [Full Text] [Related]

  • 8. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
    Findling JW, Fleseriu M, Newell-Price J, Petersenn S, Pivonello R, Kandra A, Pedroncelli AM, Biller BM.
    Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.
    Belaya ZE, Iljin AV, Melnichenko GA, Rozhinskaya LY, Dragunova NV, Dzeranova LK, Butrova SA, Troshina EA, Dedov II.
    Endocrine; 2012 Jun; 41(3):494-500. PubMed ID: 22447310
    [Abstract] [Full Text] [Related]

  • 10. Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.
    Raff H.
    Endocrine; 2013 Oct; 44(2):346-9. PubMed ID: 23839587
    [Abstract] [Full Text] [Related]

  • 11. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA.
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [Abstract] [Full Text] [Related]

  • 12. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
    Kuzu I, Zuhur SS, Demir N, Aktas G, Yener Ozturk F, Altuntas Y.
    Endokrynol Pol; 2016 Apr; 67(5):487-492. PubMed ID: 26884297
    [Abstract] [Full Text] [Related]

  • 13. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
    Yaneva M, Mosnier-Pudar H, Dugué MA, Grabar S, Fulla Y, Bertagna X.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
    [Abstract] [Full Text] [Related]

  • 14. Overnight urinary free cortisol determination: a screening test for the diagnosis of Cushing's syndrome.
    Corcuff JB, Tabarin A, Rashedi M, Duclos M, Roger P, Ducassou D.
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):503-8. PubMed ID: 9640418
    [Abstract] [Full Text] [Related]

  • 15. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F, Barbot M, Zilio M, Ferasin S, Occhi G, Daniele A, Mazzocut S, Iacobone M, Betterle C, Mantero F, Scaroni C.
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [Abstract] [Full Text] [Related]

  • 16. Biochemical diagnosis of Cushing's disease: Screening and confirmatory testing.
    Petersenn S.
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101519. PubMed ID: 33757676
    [Abstract] [Full Text] [Related]

  • 17. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 18. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
    Newell-Price J, Pivonello R, Tabarin A, Fleseriu M, Witek P, Gadelha MR, Petersenn S, Tauchmanova L, Ravichandran S, Gupta P, Lacroix A, Biller BMK.
    Eur J Endocrinol; 2020 Feb; 182(2):207-217. PubMed ID: 31804965
    [Abstract] [Full Text] [Related]

  • 19. Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations.
    Belaya Z, Golounina O, Melnichenko G, Tarbaeva N, Pashkova E, Gorokhov M, Kalashnikov V, Dzeranova L, Fadeev V, Volchkov P, Dedov I.
    Endocrine; 2021 Apr; 72(1):12-19. PubMed ID: 33713312
    [Abstract] [Full Text] [Related]

  • 20. Metyrapone treatment in Cushing's syndrome: a real-life study.
    Ceccato F, Zilio M, Barbot M, Albiger N, Antonelli G, Plebani M, Watutantrige-Fernando S, Sabbadin C, Boscaro M, Scaroni C.
    Endocrine; 2018 Dec; 62(3):701-711. PubMed ID: 30014438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.